ClinicalTrials.gg
RecruitingNCT07103993Updated Sep 30, 2026

Food Intake and Thermogenesis in High Spinal Cord Injury

An interventional study of Low meal condition and Moderate meal condition in SCI - Spinal Cord Injury, sponsored by University of Miami. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by University of Miami · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Updated Sep 30, 2026Eligibility revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 45 studies in Spinal Cord Injuries by University of Miami — 12 open to participants now, 14 under way, 1 of them phase 3. Spinal Cord Injuries · University of Miami.

Planned enrollment
6th of 37
56 · median 26
Started
2026
with 2 others
No phase
33 of 45
10 open now
Primary completion
2027-12
later than 8 of 13 live
Registered
43rd of 45
by date

Among the 45 studies in Spinal Cord Injuries by University of Miami, this one is the 6th largest by planned enrollment of the 37 interventional ones that give a count, is one of 3 that started in 2026, is one of 33 with no phase, reaches primary completion later than 8 of the 13 other live ones, and was the 43rd registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

12 of the 45 studies in Spinal Cord Injuries by University of Miami are open now, in 1 country. Recruiting first, the newest first:

6 more — sign in →

By country, each count listing its studies:

All 12 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 45 studies in Spinal Cord Injuries by University of Miami, or all of them as a file.
02

Study summary

The purpose of this research is to determine the effects of food on cardiovascular and metabolic health in men with and without spinal cord injury (SCI).

03

Conditions studied

  • SCI - Spinal Cord Injury
04

Who can participate

The criteria were revised on the registry on Sep 30, 2026. See what changed

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

SCI and Controls

  • Men and Women
  • Physically inactive (\<200 minutes per week of moderate-vigorous activity intensity for the preceding 3 months)
  • Weight stable: body mass ±3 kilograms (kg) for past 3 months

SCI Only

  • Chronic SCI (≥ 1-year post-injury)
  • Motor-complete SCI American Spinal Injury Association Impairment Scale (AIS) A and B
  • T6 injuries and above that can independently feed themselves

Exclusion criteria

Exclusion Criteria:

SCI and Controls

  • Uncompensated thyroid disease
  • Diabetes
  • Swallowing or gastrointestinal pathologies
  • Allergies or aversions to foods/ingredients
  • Prescribed prokinetic, antipsychotic, or anti-obesity agents

SCI Only

  • Incomplete SCI AIS C or D
  • Ventilator-dependent
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Participant)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Low meal condition group

    Subjects will be in this group for up to 3 weeks.

    Other: Low meal condition · Other: Ad-libitum control condition

  • Experimental
    Moderate meal condition group

    Subjects will be in this group for up to 3 weeks.

    Other: Moderate meal condition · Other: Ad-libitum control condition

  • Experimental
    High meal condition group

    Subjects will be in this group for up to 3 weeks.

    Other: High meal condition · Other: Ad-libitum control condition

Interventions

  • OtherLow meal condition

    Participants will consume a standardized meal (500 grams) with a low nutrient modification one time at one visit. Participants will attend one visit per week for 3 weeks. Each is visit separated by one week and each visit will take approximately 6 hours

  • OtherModerate meal condition

    Participants will consume a standardized meal (500 grams) with a moderate nutrient modification one time at one visit. Participants will attend one visit per week for 3 weeks. Each is visit separated by one week and each visit will take approximately 6 hours.

  • OtherHigh meal condition

    Participants will consume a standardized meal (500 grams) with a high nutrient modification one time at one visit. Participants will attend one visit per week for 3 weeks. Each is visit separated by one week and each visit will take approximately 6 hours.

  • OtherAd-libitum control condition

    The ad-libitum meal consists of 600-700 g of a standardized control meal one time at all visits. Participants will attend one visit per week for 3 weeks. Each visit is separated by one week and each visit will take approximately 6 hours.

06

What researchers measure

Primary outcomes

  1. Diet induced thermogenesis (DIT)

    Diet-induced thermogenesis (DIT) will be measured using indirect calorimetry. A portable mask-based metabolic system, which will measure expired air to calculate dietary-induced thermogenesis defined as the energy expended above resting and the proportion of meal energy expended postprandially (postprandial kilocalorie (kcal) expended/total meal kcal) where a higher value means more energy is expended.

    Time frame: up to 3 weeks (collected during each of the intervention visits)

  2. Hunger Series Visual Analog Scale

    Satiety will be measured using the Hunger Series Visual Analog Scale (HSVAS), which assesses subjective appetite. Each scale is defined at 0 as "not at all hungry" and 100 as "totally/a lot/very hungry". A sum score will be calculated.

    Time frame: up to 3 weeks (collected during each of the intervention visits)

  3. Post ad-libitum energy intake measured in grams

    This value will be expressed as a ratio of energy consumed to energy requirements (energy intake/energy requirements x 100) and will be recorded in grams.

    Time frame: up to 3 weeks (collected during each of the intervention visits)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Dec 2027, 21 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 21 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2025
First posted
Aug 5, 2025
StartActual
Mar 13, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
Maximum age 65 Years→70 Years; Sex MALE→ALL; 2 inclusion criteria edited
What changed in the criteria
Inclusion criteria
  • EditedMen and Women
  • EditedPhysically inactive (<150200 minutes per week of moderate-vigorous activity intensity for the preceding 3 months)
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    Eligibility Maximum age 65 Years→70 Years; Sex MALE→ALL; 2 inclusion criteria edited
    What changed in the criteria
    Inclusion criteria
    • EditedMen and Women
    • EditedPhysically inactive (<150200 minutes per week of moderate-vigorous activity intensity for the preceding 3 months)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07103993
Collaborators
The Craig H. Neilsen Foundation
Responsible party
Gary Farkas (Assistant Professor, University of Miami) — Principal investigator
First posted
Aug 5, 2025
Start date
Mar 13, 2026
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Sep 30, 2026

Study contacts

Guillermo Mederos
Contact
gxm1228@med.miami.edu
(305) 243-4518
Gary J Farkas, PhD
Contact
gjf50@med.miami.edu
(305) 243-4518
Gary J Farkas, PhD
principal investigator · University of Miami

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion